Focal Therapy Society

Focal Therapy Society is dedicated to the research and development of minimally invasive therapies to improve men’s health

[Focal Therapy Society @FocalSociety]

Deep respect to @LondonProstate1 Prof. Hashim Ahmed for his unwavering commitment to advancing prostate cancer care. Designing and executing RCTs comparing focal ablation to whole-gland radical treatment is notoriously difficult due to patient preferences and recruitment hurdles. Yet, he remains one of the few investigators in the world actually leading multiple prospective RCTs in this space allowing us to build the evidence base we all rely upon.

[Daniel E Spratt @DrSpratticus]

Clearly you did not read the manuscript and have minimal grasp of radiation biology. They used low dose SBRT, which did have improved QOL/reduced toxicity in select domains, but will not show superiority with those doses which are not standard today.

Most people who use that Rx give a 120% hotspot, but they did not even allow dose much over 38 Gy to hotspots!

PACE-B gave Rx of 40 Gy with hotspots over 44 Gy. This may not seem like a lot to you, but it is a big difference.

Hilarious this is coming from the biggest proponent of focal therapy who cant even run a single RCT to prove it helps patients.

[Focal Therapy Society @FocalSociety]

We applaud @LondonProstate1 Prof. Hashim Ahmed's longstanding commitment to improve the care of our patients with prostate cancer, specifically through his visionary leadership of multiple RCTs in the pioneering field of focal therapy. It is not easy to compare partial treatment with standard of care (recruitment issues etc), yet he has shown the tenacity to plan and execute these monumental efforts helping to lead the way for us all.

[Focal Therapy Society @FocalSociety]

Please join us in congratulating @pcarroll_ and Dr. Lance Mynderse, the inaugural recipients of the 2026 IMPACT Award. We are grateful for their exceptional service and contributions to the Focal Therapy Society. Don't miss our meeting in Washington, DC, September 17th-19th.
#IMPACTAward #FocalTherapy #FTS

https://t.co/VA2F09uAKv @AmerUrological @MayoUrology @UCSFUrology @Endo_Society

[Endourological Society @Endo_Society]

A first look at the #FTS_SURS26 joint program 🔬🤖
🗓️ Sep 17–19 · Arlington, VA
👉 https://t.co/yOOqHVoxOe
@SocietySURS @FocalSociety

[Hashim U. Ahmed @LondonProstate1]

📣Congratulations to Nikhil Mayor! Former Academic Clinical Fellow in Urology, currently Transform study’s Clinical Research Fellow and now an NIHR Doctoral Fellow with £0.5M awarded to him

🎉Amazing achievement!!

[Kae Jack Tay @KaeJackTay]

Where is #focaltherapy, #roboticsurgery and #precisionimaging going? Join the @FocalSociety September 17-19 for the SURS-FTS meeting.
@ALDCAbreu @vourganti @DrTanWP @DrRastinehad @ThomasPolascik @RSanchez_Salas @urobianco

[Alexander Light @AJWLight]

Fantastic to see our study covered in page 2 of @thetimes newspaper today!

[Alexander Light @AJWLight]

A career highlight to lead this study on 10 year outcomes in almost 3500 men undergoing focal therapy, now published in @EUplatinum

And fantastic to see the widespread UK media coverage today across TV, radio, and print!

Many thanks to my collaborators and mentors 🙏

[Focal Therapy Society @FocalSociety]

The capstone highlight of the FTS/SURS meeting in Sept: our joint event with @mancave_health @nflpadc featuring education, prostate ca screening, NFL players, and bourbon tasting at the @RitzCarlton. You won't want to miss this! https://t.co/0cGgvpxfqi

[Focal Therapy Society @FocalSociety]

One meeting devoted to best of Focal Therapy and Robotics? This one is not to be missed. Sept 17 to 19th... https://t.co/oWiEvjpCVA

[Hashim U. Ahmed @LondonProstate1]

✅ Focal therapy for prostate cancer is effective over the long term

🏆A win for all those eligible patients who want a treatment for their significant prostate cancer with fewer side effects

🇬🇧 Amazing ‘Team UK’ endeavour for the last two decades to get us to this point!

[Focal Therapy Society @FocalSociety]

Check out @AmerUrological aua news FTS meeting. Did you see it? Take a pic and post.

[Rafael Sanchez-Salas @RSanchez_Salas]

Kudos to @imperialurology @IP_London for providing this timely piece of information. #FocalTherapy #MovingForward @FocalSociety @AJWLight «London is calling »!

[Focal Therapy Society @FocalSociety]

Are you ready? SURS/FTS in Washington DC Sept 17th. https://t.co/rbhTnF6zAM @Cacciamani_MD @IP_London @AmerUrological @Endo_Society

[Stacy Loeb, MD @LoebStacy]

Hot off the press from #asco26 & @NEJM - the PROTEUS trial of perioperative apalutamide in high risk #prostatecancer ⬇️

[Focal Therapy Society @FocalSociety]

Ok people, this one is definitely one not to miss at #aua26 on Sunday Mornjng. @FocalSociety symposium at Marriot Marquis Indepence Ballroom Salon B. Hot ticket 🔥

[Focal Therapy Society @FocalSociety]

The data regarding focal therapy is in not one but two scientific sessions today at #AUA26, plus a great course on the evidence in prostate biopsy:

[Focal Therapy Society @FocalSociety]

This is what I'm talking about @ #AUA26: The masters at focal therapy discuss the finer points at the "Essentials in Prostate Cancer Focal Therapy" Course. The field is maturing and it great to see data driven decision making to optimize care for our pts with prostate cancer.

[Focal Therapy Society @FocalSociety]

#AUA2026 and it starts! Are you dreary for it? @AmerUrological What’s the best biopsy approach for patient on AS for prostate cancer? @wayne_brisbane @EmbertonMark Philip Dundee…. @KlotzLaurence look who won.